Alpha Teknova (TKNO) Other Non-Current Assets (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Other Non-Current Assets came in at $1.2 million in Q1 2026, down 9.4% year-on-year from $1.3 million in Q1 2025, and down 7.0% on a QoQ basis from $1.3 million in Q4 2025.
Alpha Teknova (TKNO) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Other Non-Current Assets data on file, last reported at $1.2 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 9.4% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 9.4% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 7.02% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $1.2 million, down from $1.3 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for TKNO reached as high as $2.3 million in Q4 2022 and fell as low as $396000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $1.5 million across 5 years, with a median of $1.4 million in 2024.
- Across the five-year window, Other Non-Current Assets jumped 3955.17% in 2022 and dropped 25.38% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $2.3 million in 2022, then decreased by 17.76% to $1.9 million in 2023, then fell by 25.38% to $1.4 million in 2024, then fell by 7.02% to $1.3 million in 2025, then declined by 7.0% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.2 million in Q1 2026, $1.3 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 1.85 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | 2.15 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 769,000.00 |
| Mar 31, 2022 | 396,000.00 |
| Dec 31, 2021 | 180,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Jun 30, 2021 | 31,000.00 |